Varian gets FDA nod for Trilogy applications

Radiation oncology vendor Varian Medical Systems has received 510(k) clearance from the U.S. Food and Drug Administration for new applications for its Trilogy family of linear accelerators, as well as a new Trilogy Tx image-guided radiosurgery model.

Trilogy and Trilogy Tx systems can now be used for stereotactic radiosurgery and radiotherapy for lesions, tumors, and conditions anywhere in the body when radiation treatment is indicated, according to the company. Such applications could include functional lesions like trigeminal neuralgia and other noncancerous conditions, whereas the prior FDA clearance for Trilogy was limited to benign and malignant cancers and arteriovenous malformations.

By AuntMinnie.com staff writers
May 23, 2006

Related Reading

Varian adds Swedish orders, May 16, 2006

Varian, Resonant bury hatchet, May 2, 2006

Varian posts record Q2 revenues, April 26, 2006

Varian launches Vitesse 2.0 system, April 3, 2006

Varian highlights Emory research, March 28, 2006

Copyright © 2006 AuntMinnie.com

Page 1 of 57
Next Page